Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Kloess

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Cancers|June 28, 2023
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)Juliette Nowak, Marco Bentele, Ivana Kutle, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusionSabine Huenecke, Stefanie Yvonne Zimmermann, Stephan Kloess, et al.
Frontiers in Oncology|June 5, 2013
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocolUlrike Koehl, Claudia Brehm, Sabine Huenecke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2014
Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorKurt Schönfeld, Christiane Sahm, Congcong Zhang, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Cancers|June 28, 2023
CAR-NK Cells Targeting HER1 (EGFR) Show Efficient Anti-Tumor Activity against Head and Neck Squamous Cell Carcinoma (HNSCC)Juliette Nowak, Marco Bentele, Ivana Kutle, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 11, 2010
IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusionSabine Huenecke, Stefanie Yvonne Zimmermann, Stephan Kloess, et al.
Frontiers in Oncology|June 5, 2013
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocolUlrike Koehl, Claudia Brehm, Sabine Huenecke, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2014
Selective inhibition of tumor growth by clonal NK cells expressing an ErbB2/HER2-specific chimeric antigen receptorKurt Schönfeld, Christiane Sahm, Congcong Zhang, et al.
Pageof 3